ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q2SCImago #11,252Hybrid

Experimental and Clinical Endocrinology & Diabetes

Abbreviation (ISO):EXP CLIN ENDOCR DIAB
•
Identifier (ISSN):0947-7349(Print)/1439-3646(Online)
•
Publisher:Thieme
Clarivate IF (2026)
1.8↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Experimental and Clinical Endocrinology & Diabetes

WoS Q4
12341.6220181.9320192.0620202.9520212.4320221.820231.620241.720251.82026
Annual Impact Factor Metric
Current (2026):1.8
Scopus SJR & RankScopus Q2
0.529
#11,252

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
92

92 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
139articles/year
13.51% Gold OA•93.44% Original Research

Aims & Scope

Publishing outstanding articles from all fields of endocrinology and diabetology, from molecular biology to clinical research, this journal is a brilliant resource. Since being published in English in 1983, the popularity of this journal has grown steadily, reflecting the importance of this publication within its field. Original contributions and short communications appear in each issue along with reviews addressing current topics. In addition, supplementary issues are published each year presenting abstracts or proceedings of national and international scientific meetings. The journal was initially published in German and is still the oldest endocrinological periodical in the German-language market!

Topics Covered (Recognized by AI)
Medicine98.7%Biology92.1%Internal medicine88.5%Endocrinology85.2%Chemistry67.4%Biochemistry64.1%Genetics63%Pathology44.3%Diabetes mellitus34.9%Biotechnology26.4%Hormone26.2%Insulin25.2%Psychology22.8%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q4
Rank160/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q4
Rank149/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.8
Articles / Year50
Total Citations22
2025
IF1.7
Articles / Year62
Total Citations45
2024
IF1.6
Articles / Year86
Total Citations262
2023
IF1.8
Articles / Year87
Total Citations437
2022
IF2.426
Articles / Year76
Total Citations498

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,252Scopus Q2SCImago Profile
Scopus Coverage:1983-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.529

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.61

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,979 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations481
3-Year Documents269
Citable Documents257

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ2
Medicine (miscellaneous)Q2
EndocrinologyQ3
Endocrinology, Diabetes and MetabolismQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Experimental and Clinical Endocrinology & Diabetes (abbr: EXP CLIN ENDOCR DIAB, ISSN: 0947-7349) is a peer-reviewed international scholarly journal in the field of Medicine, published by Thieme in Germany since 1995. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.529 (Q2), an H-index of 92.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 139 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,979 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Thieme
Publication Language
English
Frequency
Monthly
Founding Year
1995
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH, RUEDIGERSTR 14, STUTTGART, GERMANY, D-70469

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: aee83316-ac12-47ae-9439-2cfa556df484
Database Updated: 2026-09-28